Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5784073-O-beta-D-glucopyranosyl (1-3)-O-(beta-D-glucopyranosyl-oleanolic acid)-28-O-beta-D-glucuronopyranosideMeSH

  from Alternanthera philoxeroides; structure in first source

• C5716363-O-beta-D-glucopyranosyl(1-4)-beta-D-fucopyranosyl-(22S,24Z)-cycloart-24-en-3beta,22,26,29-tetraol 26-O-beta-D-glucopyranosideMeSH

  from Thalictrum fortunei; structure in first source

• C5716353-O-beta-D-glucopyranosyl(1-4)-beta-D-fucopyranosyl-(22S,24Z)-cycloart-24-en-3beta,22,26,30-tetraol 26-O-beta-D-glucopyranosideMeSH

  from Thalictrum fortunei; structure in first source

• C5710453-O-beta-D-glucopyranosyl(1-6)-(angeloyl(1-2))-beta-D-glucopyranosyl-28-O-alpha-L-rhamnopyranosyl(1-2)-(beta-D-glucopyranosyl(1-6))-beta-D-glucopyranosyl-21beta,22alpha-dihydroxyl-olean-12-eneMeSH

  from the husks of Xanthoceras sorbifolia Bunge; structure in first source

• C5716473-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranosyl subprogenin DMeSH

  from Abrus precatorius Linn; structure in first source

• C5843373-O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl echinocystic acidMeSH

  from the leaves of Aralia elata; structure in first source

• C5843383-O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl oleanolic acid 28-O-beta-D-glucopyranosideMeSH

  from the leaves of Aralia elata; structure in first source

• C5858753-O-beta-D-glucopyranosyl-(1-3)-beta-D-xylopyranosyl-(1-2)-(alpha-L-rhamnopyranosyl-(1-3))-beta-D-glucopyranosyl-(1-4)-(beta-D-glucopyranosyl-(1-2))-alpha-L-arabinopyranosyl-3beta,16alpha,28,30-tetrahydroxy-olean-12-eneMeSH

  isolated from the rhizomes of Ardisia gigantifolia; structure in first source

• C5710463-O-beta-D-glucopyranosyl-28-O-(beta-D-glucopyranosyl(1-2))-beta-D-glucopyranosyl-21beta,22alpha-dihydroxyl-olean-12-eneMeSH

  from the husks of Xanthoceras sorbifolia Bunge; structure in first source

• C5782073-O-beta-D-glucosyl-kaempferol-7-O-(2-O-(2(E)-2,6-dimethyl-6-hydroxy-2,7-octadienoyl))-alpha-L-rhamnosideMeSH

  from the seeds of Hippophae rhamnoides subsp. sinensis; structure in first source

• C5782093-O-beta-D-sophorosyl-kaempferol-7-O-(2-O-(2(E)-2,6-dimethyl-6-hydroxy-2,7-octadienoyl))-alpha-L-rhamnosideMeSH

  from the seeds of Hippophae rhamnoides subsp. sinensis; structure in first source

• C5782083-O-beta-D-sophorosyl-kaempferol-7-O-(3-O-(2(E)-2,6-dimethyl-6-hydroxy-2,7-octadienoyl))-alpha-L-rhamnosideMeSH

  from the seeds of Hippophae rhamnoides subsp. sinensis; structure in first source

• C5711353-O-caffeoyl-D-glucopyranoseMeSH

  from the aerial parts of Lygodium japonicum; structure in first source

• C5735113-O-debenzoylzeylenoneMeSH

  structure in first source

• C5838603-O-demethylswertipunicosideMeSH

  isolated from Swertia punicea; structure in first source

• C5616283-O-fucopyranosylsaikogenin FMeSH

  an antineoplastic agent isolated from Verbascum thapsus; structure in first source

• C5829983-O-galactopyranosyl-(1-2)-(xylopyranosyl-( 1-3))-glucuronopyranosylquillaic acid 28-O-glucopyranosyl-(1-3)-(xylopyranosyl-(1-3)-xylopyranosyl-(1-4))-rhamnopyranosyl-(1-2)-fucopyranosyl esterMeSH

  enhances toxicity of saporin; isolated from Gypsophila arrostii; structure in first source

• C5694753-O-glucopyranosyl-3,12,25-trihydroxydammar-20(22)-eneMeSH

  a ginsenoside Rh2 metabolite with antineoplastic activity; structure in first source

• C5707753-O-glucopyranosyloleanolic acid 28-O-xylopyranosyl-(1-4)-rhamnopyranosyl-(1-2)-xylopyranosideMeSH

  has antineoplastic activity; isolated from Butyrospermum parkii; structure in first source

• C5690053-O-p-coumaroyl-1-(4-hydroxy-3,5-dimethoxyphenyl)-1-O-glucopyranosylpropanolMeSH

  has anti-inflammatory activity; isolated from Sasa quelpaertensis

• C5697473-O-succinyl-lupeolMeSH

  has antineoplastic activity; structure in first source

• D0137413-Oxo-5-alpha-Steroid 4-DehydrogenaseMeSH

  An enzyme that catalyzes the reduction of TESTOSTERONE to 5-ALPHA DIHYDROTESTOSTERONE.

• D0644313-Oxoacyl-(Acyl-Carrier-Protein) ReductaseMeSH

  A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS.

• D0150993-Oxoacyl-(Acyl-Carrier-Protein) SynthaseMeSH

  An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41.

• D0644133-Phosphoinositide-Dependent Protein KinasesMeSH

  Highly conserved protein-serine threonine kinases that phosphorylate and activate a group of AGC protein kinases, especially in response to the production of the SECOND MESSENGERS, phosphatidylinositol 3,4,-biphosphate (PtdIns(3,4)P2) and phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3).

• D0512293-Phosphoshikimate 1-CarboxyvinyltransferaseMeSH

  An enzyme of the shikimate pathway of AROMATIC AMINO ACID biosynthesis, it generates 5-enolpyruvylshikimate 3-phosphate and ORTHOPHOSPHATE from PHOSPHOENOLPYRUVATE and shikimate-3-phosphate. The shikimate pathway is present in BACTERIA and PLANTS but not in MAMMALS.

• D0014983-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterMeSH

  A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.

• C5879173-acetoxy-11,19-octacosadien-1-olMeSH

  anti-aphrodisiac male pheromone from Drosophila melanogaster; structure in first source

• C5750663-acetoxy-9,13-epoxy-16-hydroxylabda-15,16-olideMeSH

  an antifungal agent isolated from Vitex negundo; structure in first source

• C5694773-acetoxyeudesma-1,4(15),11(13)-trien-12,6-olideMeSH

  has neuroprotective and antiparkinson activity; structure in first source

• C5767013-acetyl-5-methyltetronic acidMeSH

  vitamin K1 2,3-epoxide reductase (VKOR) inhibitor that reduces experimental glomerulonephritis

• C5838123-acetyl-6-hydroxy-2H-1-benzopyran-2-oneMeSH

  structure in first source

• C5622433-acetyl-7-(4-hydroxyphenyl)-2H-chromen-2-oneMeSH

  inhibits 17beta-HSD1; structure in first source

• C5794853-acetyl-7-methoxycoumarinMeSH

  structure in first source

• C5883013-acetyl-bis(2-chloro-4-nitrophenyl)triazeneMeSH

  has antineoplastic activity; structure in first source

• C5857993-acetyloxy-epicycloeucalenol-24-oneMeSH

  from stem and leaf of Quercus variabilis; structure in first source

• D0450023-alpha-Hydroxysteroid Dehydrogenase (B-Specific)MeSH

  A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.

• C5781893-alpha-propionyloxy-beta-boswellic acidMeSH

  has antineoplastic activity; structure in first source

• C5755813-amino-1,2,4-triazoliumMeSH
• C5754273-amino-2,2-dimethylpropanamideMeSH

  degradation product of aliskiren; structure in first source

• C5611753-amino-2,5,7,8-tetrahydroxy-10-methylundecanoic acidMeSH

  structure in first source

• C5623263-amino-2-hydroxy-4-phenylbutanoylvalylisoleucineMeSH

  an aminopeptidase inhibitor; structure in first source

• C5616923-amino-3-deoxy-ribofuranoseMeSH

  structure in first source

• C5763363-amino-4-(methyamino)butanoic acidMeSH

  structure in first source

• C5842113-amino-4-(methyl(phenyl)amino)-1H-isochromen-1-oneMeSH

  structure in first source

• C5842103-amino-4-anilino-1H-isochromen-1-oneMeSH

  structure in first source

• C5747743-amino-6-(3'-aminopropyl)-5H-indeno(1,2-c)isoquinoline-5,11-(6H)dioneMeSH

  a retinoid X receptor ligand; structure in first source

• C5735483-amino-6-(3,4-dichlorophenyl)thieno(2,3-b)pyridine-2-carboxamideMeSH

  an antineoplastic activity; structure in first source

• C5742303-amino-6-(3-methoxyphenyl)thieno(2.3-b)pyridine-2-carboxamideMeSH

  has antineoplastic activity; structure in first source

• C5605803-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamideMeSH

  an antineoplastic agent; structure in first source